Eminent Global Leader in HealthTech industry, research and commercialization, with over 25 years in the field.
Partner in Par Equity LLP. Chairman of ProMetic Life Sciences Inc., a Canadian biopharmaceutical company; CEO of the Roslin Institute company exploiting medical applications of the technology that produced Dolly the Sheep. Past Vice-Chairman of the U.S. Biotechnology Industry Organization and Chairman of the U.K. BioIndustry Association. Fellow of the Royal Society of Edinburgh, Order British Empire, and Visiting Professor of Medicine at the University of Edinburgh.
Based in Edinburgh.